🇺🇸 FDA
Pipeline program

conivaptan

087-CL-071

Phase 2 small_molecule completed

Quick answer

conivaptan for Chronic Heart Failure is a Phase 2 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
CUMBERLAND PHARMACEUTICALS INC
Indication
Chronic Heart Failure
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials